🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Shanghai
Clinical trial register · China

Clinical Trials in Shanghai, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Fudan University454 Ruijin Hospital276 Shanghai Zhongshan Hospital163 RenJi Hospital135 Children's Hospital of Fudan University84
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to

Trials with a site in Shanghai

3827 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Active, closed
Pharmacokinetic, Safety and Immunogenicity Study of New Process CMAB015 and Cosentyx in Healthy Volunteers
NCT07254325Psoriasis
Taizhou Mabtech Pharmaceutical Co.,Ltd
Phase 1
114
Shanghai
2025-12-15
Recruiting
IRE Combined With the Dual-Function Antibody PD-1/CTLA-4 for the Treatment of LAPC Following Failure of First-Line AG Therapy
NCT07306273Pancreatic Adenocarcinoma Locally Advanced
Ruijin Hospital
Phase 2
20
Shanghai
2025-12-15
Recruiting
Adjuvant Oxaliplatin Plus S-1 Versus Docetaxel Plus S-1 for Stage III Gastric Cancer
NCT07366528Gastric Cancer (GC), Adjuvant Chemotherapy, Stage 3 Cancer, Docetaxel
DrugsTegafur Gimeracil Oteracil·Oxaliplatin·Paclitaxel
Ruijin Hospital
Phase 3
387
Shaoguan, Shanghai
2025-12-15
Not yet open
Evaluating the Clinical Value of Transparent Cap-Assisted Second Examination of the Sigmoid Colon for Improving Colorectal Adenoma Detection Rates
NCT07261319Colorectal Adenoma
Fudan University
Not applicable
614
Shanghai
2025-12-15
Recruiting
Near-infrared Light Therapy Device for Mild-Moderate Alzheimer's Disease (NirsCure-03A)
NCT07262645Alzheimer s Disease
Danyang Huichuang Medical Equipment Co., Ltd.
Phase 3
320
Beijing, Shijiazhuang, Baotou, Suzhou, Xi'an, Shanghai, Taiyuan, Tianjin
2025-12-15
Recruiting
Study Comparing ZG006 With Investigator-Selected Chemotherapy in Participants With Relapsed Small Cell Lung Cancer
NCT07189455Small-cell Lung Cancer
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Phase 3
420
Shanghai
2025-12-12
Recruiting
AI System for Anatomic Recognition & Lesion Detection in Nasopharyngolaryngoscopy: A Prospective Study
NCT07326358Nasopharyngeal Neoplasms, Laryngeal Disease
Ruijin Hospital
Observational
500
Shanghai
2025-12-12
Recruiting
An Investigational Study of BG-75202 Alone and in Combination With Other Therapeutic Agents in Adults With Advanced Solid Tumors
NCT07222267Breast Cancer, Advanced Solid Tumor
DrugBG-75202
BeOne Medicines
Phase 1
86
Beijing, Chongqing, Xiamen, Guangzhou, Harbin, Nanjing, Shanghai, Tianjin
2025-12-11
Recruiting
A Study of the Efficacy and Safety of Extracorporeal Carbon Dioxide Removal Using PrismaLung+
NCT07326215Acute Respiratory Distress Syndrome, Acute Kidney Injury
Vantive Health LLC
Not applicable
99
Beijing, Guangzhou, Shenzhen, Harbin, Nanjing, Nanchang, Shanghai, Chengdu
2025-12-11
Not yet open
A Study of ABSK061 to Assess Safety, Tolerability, Pharmacokinetics, and Efficacy in Children With Achondroplasia
NCT07297875Achondroplasia
DrugABSK061
Abbisko Therapeutics Co, Ltd
Phase 1/2
110
Beijing, Zhengzhou, Wuhan, Shanghai, Chengde, Chengdu, Hangzhou
2025-12-10
Not yet open
The Percutaneous Interventional Surgery Control System for Pulmonary Nodule Biopsy
NCT07277088Pulmonary Nodules, Lung Cancer (Diagnosis), Percutaneous Needle Biopsy, Transthoracic Needle Biopsy
Jiayuan Sun
Not applicable
158
Shanghai
2025-12-10
Recruiting
A Clinical Study to Evaluate LVIVO-TaVec200 for the Treatment of Relapsed/Refractory Multiple Myeloma
NCT07294625Multiple Myeloma
The First Affiliated Hospital with Nanjing Medical University
Phase EARLY_PHASE1
36
Zhengzhou, Nanjing, Xuzhou, Shanghai, Xi’an
2025-12-10
Recruiting
A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
NCT07155187Non-Small Cell Lung Cancer
DrugsTelisotuzumab Adizutecan·Osimertinib
AbbVie
Phase 2/3
490
Guangzhou, Nanchang, Shanghai, Ürümqi
2025-12-10
Not yet open
Impact of Discontinuing GLP-1 Receptor Agonists for Two Weeks Prior to Upper Endoscopy on the Risk of Gastric Retention
NCT07276763Gastric Retention
Fudan University
Observational
16,509
Shanghai
2025-12-10
Recruiting
A Study on the Treatment of Patients With Acute Lung Injury Caused by Sepsis Through Microbiota Transplantation
NCT07342205Acute Respiratory Distress Syndrome (ARDS), Acute Lung Injury(ALI), Sepsis Related Acute Lung Injury/Acute Respiratory Distress Syndrome
Shanghai University of Traditional Chinese Medicine
Phase 2/3
60
Shanghai
2025-12-10
Recruiting
Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung Cancer
NCT07226999Small Cell Lung Cancer (SCLC)
DrugsPF-08634404·Atezolizumab
Pfizer
Phase 2/3
550
Guangzhou, Shanghai
2025-12-09
Recruiting
A Clinical Study of Glycerol Phenylbutyrate in Chinese Patients With Urea Cycle Disorders
NCT06904027Urea Cycle Disorders
Tongji Hospital
Observational
40
Beijing, Guangzhou, Wuhan, Shanghai, Hangzhou
2025-12-09
Recruiting
TITAN-HCC: Neoadjuvant and Adjuvant QL1706 With TACE in Resectable Hepatocellular Carcinoma Beyond Milan Criteria
NCT07268131Hepatocellular Carcinoma (HCC)
Fudan University
Not applicable
30
Shanghai
2025-12-09
Recruiting
HC010 in First-line PD-L1 Positive Advanced NSCLC Patients
NCT07169552NSCLC
DrugHC010
HC Biopharma Inc.
Phase 2
50
Shanghai
2025-12-09
Recruiting
A Study on a Predictive Model for Efficacy and Prognosis of Pancreatic Carcinoma Based on Multimodal Data
NCT07561814Pancreatic Cancer
Shanghai Zhongshan Hospital
Observational
1,030
Shanghai
2025-12-09
Recruiting
A Study of Solbinsiran (LY3561774) in Participants With Severe Hypertriglyceridemia
NCT07269210Severe Hypertriglyceridemia
Eli Lilly and Company
Phase 2
60
Beijing, Chengdu, Guangzhou, Luoyang, Shanghai, Xuzhou
2025-12-08
Not yet open
A First-in-Man Clinical Trial to Evaluate the Safety and Feasibility of ICS-Elpis in Patients With Iliac Artery Stenosis or Occlusion Lesions
NCT07290101Iliac Artery Stenosis, Iliac Artery Occlusion
Biotyx Medical (Shenzhen) Co., Ltd.
Not applicable
15
Shanghai
2025-12-08
Recruiting
Analysis of Factors Influencing the Quality of Bowel Preparation Before Colonoscopy in IBD Patients
NCT07335705IBD (Inflammatory Bowel Disease), Colonoscopy, Colonoscopy: Bowel Preparation
Changhai Hospital
Observational
1,000
Shanghai
2025-12-08
Recruiting
Toripalimab Combined With BCG Perfusion for the Treatment of HR-NMIBC After TURBT Surgery Exploration
NCT07307456Bladder Cancer
Changhai Hospital
Phase 2
31
Shanghai
2025-12-08
Not yet open
Improving Chemotherapy Induced Peripheral Neuropathy in Children With Leukemia: A Study of Transcutaneous Acupoints Electrical Stimulation and Auricular Acupressure Interventions
NCT07279818Chemotherapy Induced Peripheral Neuropathy (CIPN)
The Hong Kong Polytechnic University
Not applicable
132
Shanghai
2025-12-08
Recruiting
A Study to Evaluate the Efficacy and Safety of IBI302inSubjects With nAMD
NCT07275840Neovascular Age-related Macular Degeneration
DrugIBI302
Innovent Biologics Technology Limited (Shanghai R&D Center)
Phase 2
800
Shanghai
2025-12-05
Recruiting
A Long-Term Study of Zasocitinib in Children and Teenagers With Plaque Psoriasis
NCT07250802Plaque Psoriasis
DrugZasocitinib
Takeda
Phase 3
110
Beijing, Guangzhou, Changsha, Hangzhou, Shanghai
2025-12-04
Recruiting
A Trial of HRS-4508 Combined With Other Antitumor Therapies in Subjects With Locally Advanced or Metastatic Non-small Cell Lung Cancer
NCT07232849Lung Cancer
DrugHRS-4508
Jiangsu HengRui Medicine Co., Ltd.
Phase 2
100
Shanghai, Hangzhou
2025-12-04
Recruiting
Clinical Trial of VBC103 in Patients With Advanced Malignant Solid Tumors
NCT07299747Participants With Advanced Solid Tumor Malignancies
VelaVigo Bio Inc
Phase 1/2
255
Shanghai
2025-12-04
Recruiting
A Study of Valemetostat (DS-3201b) in Combination With Darolutamide in Metastatic Castration Resistant Prostate Cancer (mCRPC)
NCT07244341Metastatic Castration-resistant Prostate Cancer
DrugsValemetostat·Darolutamide
Daiichi Sankyo
Phase 1
60
Guangzhou, Shanghai, Wenzhou
2025-12-03
Recruiting
A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy
NCT07218926Gastrointestinal Neoplasms
DrugsIDRX-42·Sunitinib
GlaxoSmithKline
Phase 3
450
Shijiazhuang, Shanghai, Beijing, Chengdu, Chongqing, Guangzhou, Hangzhou, Jinan
2025-12-03
Recruiting
A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
NCT06979453Plaque Psoriasis
DrugDeucravacitinib
Bristol-Myers Squibb
Phase 3
366
Beijing, Guangzhou, Shenzhen, Handan, Zhengzhou, Changsha, Jinan, Shanghai
2025-12-03
Recruiting
A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema
NCT06807281Atopic Dermatitis
DrugAbrocitinib
Pfizer
Phase 3
500
Beijing, Shenzhen, Changsha, Nanchang, Hangzhou, Shanghai
2025-12-02
Recruiting
Treponemal Shedding, Load, and Viability, in Women and Men-who-have-sex-with-women-only With Early Infectious Syphilis: Implications for Transmission
NCT07300254Syphilis
Monash University
Observational
480
Shanghai
2025-12-02
Recruiting
A Study of Belumosudil in Children With Chronic Graft Versus Host Disease (schoolROCK)
NCT07116031Chronic Graft Versus Host Disease
DrugBelumosudil
Sanofi
Phase 2
37
Beijing, Shanghai, Shenzhen, Suzhou
2025-12-02
Not yet open
High Intensity Alternating Current Stimulation as a Neuromodulation Therapy for Alcohol Use Disorder: A Pilot Study
NCT07227545Alcohol Use Disorder (AUD)
Shanghai Mental Health Center
Not applicable
18
Shanghai
2025-12-01
Recruiting
Asiaticoside for Treating Overweight/Obesity
NCT07241533Overweight , Obesity
Shanghai Zhongshan Hospital
Not applicable
30
Shanghai
2025-12-01
Not yet open
The Effect of Immersive Virtual Reality Treatment With Cognitive Behaviour Therapy for Obsessive-Compulsive Disorder
NCT04534907Obsessive-Compulsive Disorder, Virtual Reality
Shanghai Mental Health Center
Not applicable
30
Shanghai
2025-12-01
Recruiting
Niaoduqing Granules in Older Adults With Impaired Kidney Function
NCT07741292Chronic Kidney Disease
Huashan Hospital
Phase 4
300
Shanghai
2025-12-01
By invitation
Evaluation of the Efficacy and Safety of Palmitoleic Acid Oil Composition in Preventing Pressure Injuries
NCT07547254Pressure Ulcer Prevention
Ruijin Hospital
Not applicable
60
Shanghai
2025-12-01
Recruiting
STROKE 120 ACTION Trial
NCT07135310Ischemic Stroke
Shanghai Minhang Central Hospital
Not applicable
1,696,000
Shanghai
2025-12-01
Recruiting
Synthetic PET From CT Improves Precision Diagnosis and Treatment of Lung Cancer: a Prospective, Observational, Multicenter Study
NCT07243873Lung Cancer, PET-CT
Shanghai Pulmonary Hospital, Shanghai, China
Observational
10,000
Zunyi, Jiangxi, Shanghai, Ningbo
2025-12-01
Recruiting
Phase 4 Study Evaluating Efficacy and Safety of Rozanolixizumab in Adult Chinese Participants With Generalized Myasthenia Gravis
NCT07246564Myasthenia Gravis
UCB Biopharma SRL
Phase 4
40
Beijing, Changchun, Changsha, Fuzhou, Guangzhou, Jinan, Shanghai, Shenzhen
2025-12-01
Not yet open
A Randomized Trial of Surgical Decision-Making Guided by TDTP-RECIST
NCT07208526Intrahepatic Cholangiocarcinoma (Icc), Conversion Therapy, TDTP-RECIST, GOLP Regimen
Shanghai Zhongshan Hospital
Not applicable
270
Shanghai
2025-12-01
Recruiting
Valsalva SBP Drop and LVOT Obstruction
NCT07483125HCM, oHCM, nHCM
Shanghai Zhongshan Hospital
Observational
800
Shanghai
2025-12-01
Active, closed
Research on the Application of Decision Tree in Child Life
NCT07325890Psychosocial Intervention, Non-Randomized Controlled Trials
Children's Hospital of Fudan University
Not applicable
40
Shanghai
2025-12-01
Recruiting
Clinical Treatments in Specialized Diseases of Laryngeal Carcinoma (LC) and Hypopharyngeal Carcinoma (HPC)
NCT04908696Glottic Carcinoma, Supraglottic Carcinoma, Subglottic Carcinoma, Pyriform Sinus Carcinoma
Eye & ENT Hospital of Fudan University
Observational
1,000
Shanghai
2025-12-01
Recruiting
DV+BCG in HER2-Expressing, BCG-Naïve High-Risk NMIBC
NCT07207824Bladder (Urothelial, Transitional Cell) Cancer, NMIBC
Fudan University
Phase 3
182
Shanghai
2025-12-01
Recruiting
A Phase 1/1b Study to Evaluate Safety, Tolerability and Pharmacokinetics of ZL-1503 in Healthy Volunteers and Participants With Moderate to Severe Atopic Dermatitis
NCT07235384Atopic Dermatitis (AD)
Zai Lab (Shanghai) Co., Ltd.
Phase 1
84
Beijing, Jinan, Shanghai, Hangzhou
2025-12-01
Recruiting
Prevention of Atrial Fibrillation After Cardiac Surgery by Pericardiotomy
NCT06728826Atrial Fibrillation (AF), Cardiac Events, Pericardial Effusion
Changhai Hospital
Not applicable
650
Shanghai
2025-12-01
Not yet open
EFG vs IVIG in TAMG
NCT07231523Efgartigimod, Intravenous Immunoglobulin, Myasthenia Gravis Associated With Thymoma
Shanghai Zhongshan Hospital
Phase 3
64
Shanghai
2025-12-01
Not yet open
A Phase 2 Study of BB102 in Patients With Hepatocellular Carcinoma
NCT07239986Hepatocellular Carcinoma (HCC)
DrugBB102
Broadenbio Ltd., Co.
Phase 2
60
Hefei, Shanghai
2025-12
Not yet open
A First-in-Human Safety and Pharmacokinetic Trial of GenSci142 Administered as Single Ascending Doses in Healthy Chinese Women
NCT07302035Bacterial Vaginosis
DrugGenSci142
Changchun GeneScience Pharmaceutical Co., Ltd.
Phase 1
30
Shanghai
2025-12
Not yet open
Application of Quantum Detection-Driven Artificial Intelligence Algorithms for Single-Molecule cfDNA Characterization in the Early Diagnosis of Prostate Cancer
NCT07238959Benign Prostate Hypertrophy(BPH), Prostate Cancer (Diagnosis), Prostate Neoplasm
Shanghai Changzheng Hospital
Observational
1,100
Beijing, Guangzhou, Nanjing, Suzhou, Shanghai, Chengdu, Ningbo
2025-12
Recruiting
Phase II Study of Weekly Paclitaxel/Nab-Paclitaxel, Pembrolizumab, and Mirabegron for Recurrent Ovarian Cancer
NCT07261683Ovarian Cancer, Immunotherapy, Pembrolizumab
Obstetrics & Gynecology Hospital of Fudan University
Phase 2
20
Shanghai
2025-12
Not yet open
CONVERT-HB1: Radical Prostatectomy After Systemic Therapy for High-volume Metastatic Hormone-sensitive Prostate Cancer
NCT07268794Metastatic Prostate Cancer, Prostate Cancer (Adenocarcinoma), Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
DrugPaclitaxel
Fudan University
Phase 2
112
Shanghai
2025-11-30
Not yet open
Ganagliflozin on the Progression of Kidney Disease in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease
NCT07116928T2DM (Type 2 Diabetes Mellitus), CKD - Chronic Kidney Disease
DrugGanagliflozin
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Phase 4
1,244
Shanghai
2025-11-30
Recruiting
Safety Trial of 68Ga/177Lu-NRT6020 in FAP-Positive Advanced Solid Tumor Patients
NCT06911489Solid Tumor Malignancy
DrugPCV20
Chengdu New Radiomedicine Technology Co. LTD.
Phase 1
132
Shanghai, Tianjin
2025-11-29
Recruiting
Feasibility Study of Diaphragm Synchronized Pacing (DSP) Via the Left Inferior Phrenic Vein (LIPV) Approach
NCT07392749Heart Failure
RenJi Hospital
Not applicable
10
Shanghai
2025-11-28
Recruiting
A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Bevacizumab in Adult Participants With Ovarian Cancer
NCT07278336Ovarian Cancer
DrugBevacizumab
AbbVie
Phase 1
219
Guangzhou, Jinan, Shanghai
2025-11-27
Recruiting
Single-dose,First-in-human of KLA478
NCT07240675Healthy Volunteers
Hunan Kelun Pharmaceutical Co., Ltd.
Phase 1
40
Shanghai
2025-11-26
Recruiting
A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung Cancer
NCT07155174Small Cell Lung Cancer
DrugsABBV-706·Lurbinectedin·Atezolizumab·Etoposide
AbbVie
Phase 2
180
Beijing, Zhengzhou, Wuhan, Nanchang, Shanghai, Chengdu
2025-11-25
Recruiting
Targeted Induction Therapy for Stage III Unresectable EGFR Mutant Positive NSCLC
NCT07742332EGFR, NSCLC (Non-small Cell Lung Cancer), Locally Advanced Non-Small Cell Lung Cancer, Radiotherapy
Peng Zhang
Phase 2
160
Shanghai
2025-11-25
Not yet open
Efficacy and Safety of Stapokibart in Non-Allergic Rhinitis With Eosinophilia Syndrome
NCT07240376Non-Allergic Rhinitis With Eosinophilia Syndrome
DrugStapokibart
Huazhong University of Science and Technology
Not applicable
90
Guangzhou, Wuhan, Xiangyang, Nanchang, Chengdu, Beijing, Shanghai
2025-11-25
Recruiting
A Study of Brenipatide in Adult Participants With Bipolar Disorder (RENEW-Bipolar-1)
NCT07286175Bipolar Disorder
DrugBrenipatide
Eli Lilly and Company
Phase 2
400
Changsha, Hangzhou, Huzhou, Jinan, Shanghai, Shijiazhuang, Tianjin, Xiamen
2025-11-24
Recruiting
Taurine's Therapeutic Effect on Acute Radiation-induced Oral Mucositis and Dermatitis
NCT07029178Radiation Induced Oral Mucositis, Radiodermatitis
DrugTaurine
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Phase 2
160
Shanghai
2025-11-24
Not yet open
Subthalamic Nucleus Versus Globus Pallidal Internus Deep Brain Stimulation for Parkinson Disease
NCT07250685PD - Parkinson's Disease
Zhang Jianguo
Not applicable
86
Beijing, Wuhan, Nanjing, Dalian, Jinan, Shanghai, Tianjin, Hangzhou
2025-11-24
Recruiting
A Platform Study in Non-Small Cell Lung Cancer (NSCLC)
NCT06996782Advanced or Metastatic Non-small Cell Lung Cancer
DrugsRamucirumab·Rilvegostomig·Nab-paclitaxel·Pemetrexed
AstraZeneca
Phase 1/2
152
Chengdu, Chongqing, Deyang, Fuzhou, Guangzhou, Jinan, Shanghai, Shenyang
2025-11-24
Recruiting
JN002 for the Treatment of Dry Eye Disease
NCT07245017Dry Eye
Eye & ENT Hospital of Fudan University
Phase EARLY_PHASE1
30
Shanghai
2025-11-24
Recruiting
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Preliminary Efficacy of BC2027 in Patients With Advanced Solid Malignancies
NCT07368478Advanced Solid Malignancies
Biocity Biopharmaceutics Co., Ltd.
Phase 1
180
Shanghai
2025-11-24
Recruiting
Multi-center Randomized Controlled Clinical Study of Shenling Baishu Granule to Prevent the Recurrence of Low-risk Colorectal Adenoma
NCT06930157Low-risk Colorectal Adenoma
Shanghai Jiao Tong University School of Medicine
Phase 4
624
Shanghai
2025-11-24
Recruiting
HRS 4642 Injection Combined With AG Versus Placebo Combined With AG Therapy in First-Line Advanced or Metastatic Pancreatic Cancer
NCT07232875KRAS G12D-Mutant Advanced or Metastatic Pancreatic Cancer in the First-line Setting
Jiangsu HengRui Medicine Co., Ltd.
Phase 3
588
Shanghai
2025-11-21
Recruiting
Asymptomatic TB With Innovative Modified Short-course Regimens
NCT06153069Tuberculosis
Huashan Hospital
Phase 4
426
Beijing, Liupanshui, Nayong, Shanghai, Hangzhou
2025-11-21
Recruiting
Exploratory Trial of Navigational Bronchoscopy-Guided Cryoablation in Lung Cancer Treatment
NCT07301411Lung Malignancies
Tianjin Puli Ark Medical Technology Co., Ltd.
Not applicable
40
Shanghai
2025-11-21
Recruiting
Safety and Efficacy Evaluation of Cryoablation in the Treatment of Ground-Glass Nodules
NCT07232433Lung Cancer
Ruijin Hospital
Not applicable
90
Shanghai
2025-11-21
Not yet open
Effectiveness of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitor Initiation Before Percutaneous Coronary Intervention on Acute Myocardial Infarction Patients
NCT06683131Acute Myocardial Infarction (AMI)
The Affiliated Hospital of Xuzhou Medical University
Phase 4
1,160
Fuyang, Huai'an, Lianyungang, Nanjing, Suqian, Xuzhou, Beijing, Shanghai
2025-11-20
Not yet open
Perirenal Adipose Tissue Modification Therapy for Resistant Hypertension
NCT07232966Resistant Hypertension
Yan Li
Phase 3
220
Shanghai
2025-11-20
Recruiting
A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema
NCT07216027Atopic Dermatitis, Eczema, Atopic
DrugPF-08049820
Pfizer
Phase 2
165
Shanghai, Beijing
2025-11-20
Active, closed
Adaptive DBS Algorithm for Personalized Therapy in Parkinson's Disease (ADAPT-PD) China Study
NCT07216976Parkinson's Disease
MedtronicNeuro
Not applicable
61
Beijing, Guangzhou, Shanghai, Chengdu
2025-11-19
Recruiting
Sintilimab Combined With Bevacizumab Biosimilar as Adjuvant Treatment After Resection of Ruptured Hepatocellular Carcinoma (CLEAR-2)
NCT07331883Hepatocellular Carcinoma (HCC)
DrugsBevacizumab biosimilar·Sintilimab
Ruijin Hospital
Phase 2
35
Sanming, Changchun, Shanghai
2025-11-17
Recruiting
Evaluate the Safety, Tolerability, and Preliminary Efficacy of EVM14 Alone and in Combination in Patients With Selected Solid Tumors
NCT07095868Selected Types of Solid Tumor
Everest Medicines (Beijing) Co., Ltd.
Phase 1/2
94
Changsha, Nanjing, Shanghai
2025-11-17
Recruiting
Study Evaluating Safety of BT01001 Ophthalmic Solution
NCT07313722Healthy
Beyang Therapeutics Co., Ltd.
Phase 1
32
Shanghai
2025-11-17
Recruiting
An Exploratory Clinical Study on the Safety and Efficacy of Anti-CD19/BCMA U CAR-T Cells in the Treatment of Relapsed/Refractory Immune-mediated Kidney Disease
NCT07241468Relapsed/Refractory Immune Nephropathy, Relapsed/Refractory Immune-mediated Kidney Disease
Changhai Hospital
Phase EARLY_PHASE1
36
Shanghai
2025-11-15
Recruiting
Real-world Outcomes of Peripheral T-cell Lymphoma: A Multicenter Retrospective and Prospective Cohort Study
NCT07270861Peripheral T-Cell Lymphoma
Fudan University
Observational
3,000
Shanghai
2025-11-15
Recruiting
Neural Mechanisms of Temporal Interference Stimulation on Improving Social Reward Function in Depression
NCT07287878Depression
Shanghai Mental Health Center
Not applicable
120
Shanghai
2025-11-15
Recruiting
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study to Evaluate the Safety and Efficacy of Onradivir Tablets in Participants Aged 12 to 17 Years With Uncomplicated Influenza A.
NCT07229547Influenza
Ruijin Hospital
Phase 3
150
Shanghai
2025-11-14
Recruiting
A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Palmoplantar Pustulosis
NCT07219420Palmoplantar Pustulosis
DrugBimekizumab
UCB Biopharma SRL
Phase 3
320
Beijing, Chengdu, Chongqing, Guangzhou, Hangzhou, Jinan, Shanghai, Shenzhen
2025-11-14
Recruiting
A Clinical Study of PA5 in Patients With Advanced Solid Tumors
NCT07702162Advanced Solid Tumors, Cancer
Chongqing Peg-Bio Biopharm Co., Ltd.
Phase 1
49
Fuzhou, Shanghai
2025-11-14
Not yet open
Diagnostic Accuracy of Oral Images, OPGs, and Questionnaires vs. Clinical Assessment for Periodontal Disease
NCT07164573Periodontal Diseases, Gingivitis, Periodontitis
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Observational
2,000
Shanghai
2025-11-13
Recruiting
A Study of Sirolimus (Albumin-Bound) in Combination With Different ADCs Treatment of Advanced Solid Tumors
NCT07241936Advanced Solid Tumors
DrugsDP303c·SYS6010·SYS6043·Paclitaxel
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Phase 1/2
444
Shanghai
2025-11-13
Recruiting
First-in-human Study of 7MW4911 in Patients With Advanced Solid Tumors
NCT07265622Solid Tumors
Drug7MW4911
Mabwell (Shanghai) Bioscience Co., Ltd.
Phase 1/2
200
Shanghai
2025-11-12
Recruiting
Prospective Multicenter Real-world Study of Surufatinib in Patients With Advanced Neuroendocrine Neoplasms
NCT07272512Neuroendocrine Tumors, Neuroendocrine Neoplasms
DrugSurufatinib
Shanghai Zhongshan Hospital
Phase 4
350
Shanghai
2025-11-11
Active, closed
Comparative Study of EnliTuo® Before and After Technology Change in Healthy Male Volunteers
NCT07246291Healthy Adult Male
Taizhou Mabtech Pharmaceutical Co.,Ltd
Phase 1
86
Shanghai
2025-11-11
Recruiting
Treatment of Pediatric Bronchiolitis Obliterans by Airway Basal Stem Cells
NCT07239895Pediatric Bronchiolitis Obliterans
Regend Therapeutics
Phase EARLY_PHASE1
12
Shanghai
2025-11-11
Recruiting
Study of TI-0093 Injection With Recurrent/Metastatic HPV-16 Positive Solid Tumors
NCT07081984HPV 16+ Recurrent or Metastatic Cancer, HNSCC, Cervical Cancer
Therorna
Phase 1
12
Shanghai
2025-11-11
Recruiting
Symplicity China Study
NCT07081243Resistant Hypertension
Medtronic Vascular
Observational
500
Shanghai
2025-11-11
Recruiting
A First-in-Human Study of BG-C0902 Alone and in Combination With Other Therapeutic Agents in Patients With Advanced Solid Tumors
NCT07181681Solid Tumors, Advanced Solid Tumor
BeOne Medicines
Phase 1
63
Beijing, Chongqing, Xiamen, Zhengzhou, Shanghai, Chengdu, Hangzhou
2025-11-10
Active, closed
A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial Hypertension Who Have Previously Participated in a Clinical Study With PF-07868489
NCT07073820Pulmonary Hypertension
Pfizer
Phase 2
42
Guangzhou, Changsha, Nanjing, Shanghai
2025-11-10
Recruiting
Safety, Tolerability and Pharmacokinetics of AZD1613 in Adults With Autosomal Dominant Polycystic Kidney Disease
NCT07228364Autosomal Dominant Polycystic Kidney Disease
DrugAZD1613
AstraZeneca
Phase 1
40
Chengdu, Hangzhou, Nanjing, Shanghai, Wuhan, Xiamen
2025-11-10
Not yet open
Analgesic Effect of TENS-WAA Combined With Tramadol Hydrochloride During Oocyte Retrieval Surgery
NCT07212127Oocyte Retrieval for IVF, Pain
First Affiliated Hospital of the Chinese People's Liberation Army Naval Medical University
Not applicable
60
Shanghai
2025-11-08
Rows per page Showing 901–1000 of 3827
Previous 8 9 10 11 12 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 25 September 2026. https://priyalifescience.com/clinical-trials-china/city/shanghai?page=10

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 3,827 of those studies with a site in Shanghai.

How many clinical trials are recruiting in Shanghai?

2,393 of the 3,827 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 737 have not yet opened recruitment, 588 are active but closed to new participants, and 109 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.